Description:
Lung Cancer is an international publication covering the clinical, translational and basic science of
malignancies of
the
lung and
chest region.
Original research articles, early reports, review articles and editorials covering the
prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment
modalities, other treatment modalities and outcomes of
lung cancer are all welcome. Letters to the journals are also welcomed
although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results
of a research topic and will be expedited through peer-review.
Manuscripts describing studies on cell lines will only be considered
if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the
biology of
chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of
the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial
suppliers.
Manuscripts should be submitted online at
http://ees.elsevier.com/lungcancer and the instructions on this
site should be closely followed.
